VBI Vaccines
Latest round
- Series A
Last raised
- Jan 2007
Total raised
- $36M
Investors
- 3
About VBI Vaccines
VBI Vaccines Inc.Founded in 2001, VBI Vaccines Inc. operates out of Cambridge, US, specializing in vaccine development. The company went public in February 2012 and has completed 19 deals to date. The current CEO is Jeffrey Baxter, while Kelley Carson is also noted in leadership.VBI Vaccines Inc. specializes in developing innovative vaccine and immunotherapeutic candidates designed to enhance the human immune system's ability to prevent and combat significant infectious diseases and aggressive cancers. The company's primary product offerings leverage virus-like particle (VLP) technology, closely mimicking the natural presentation of viruses to elicit robust immune responses. Their flagship products include vaccine candidates targeting highly contagious infectious diseases and fast-growing cancers, addressing significant unmet public health needs on a global scale.92 mn. The company generates revenue through partnerships and collaborations with various stakeholders in the healthcare ecosystem, including governmental agencies, research institutions, and pharmaceutical companies.VBI Vaccines Inc. aims to enhance its product offerings with new vaccine candidates designed to address emerging infectious diseases and cancer types. The company is exploring expansion opportunities into European and Asian markets, with plans to launch these initiatives by 2025.00 mn will support the development of new products and facilitate entry into these new geographic regions.
Who invested in VBI Vaccines
3 investors across 1 round
See all investors in VBI Vaccines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 4, 2007
Amount
$36M
Investors
Questions about VBI Vaccines
Who invested in VBI Vaccines?
VBI Vaccines has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VBI Vaccines raised?
VBI Vaccines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did VBI Vaccines last raise money?
VBI Vaccines's most recent round on record is a Series A, in Jan 2007.
What does VBI Vaccines do?
VBI Vaccines is a biotechnology company.
Where is VBI Vaccines headquartered?
VBI Vaccines is headquartered in Cambridge, US.
Which VCs invest in companies like VBI Vaccines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VBI Vaccines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like VBI Vaccines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.